185 related articles for article (PubMed ID: 35699443)
1. Efficacy of Cochleated Amphotericin B in Mouse and Human Mucocutaneous Candidiasis.
Desai JV; Urban A; Swaim DZ; Colton B; Kibathi LW; Ferrè EMN; Stratton P; Merideth MA; Hunsberger S; Matkovits T; Mannino R; Holland SM; Tramont E; Lionakis MS; Freeman AF
Antimicrob Agents Chemother; 2022 Jul; 66(7):e0030822. PubMed ID: 35699443
[TBL] [Abstract][Full Text] [Related]
2. Antifungal activity of amphotericin B cochleates against Candida albicans infection in a mouse model.
Zarif L; Graybill JR; Perlin D; Najvar L; Bocanegra R; Mannino RJ
Antimicrob Agents Chemother; 2000 Jun; 44(6):1463-9. PubMed ID: 10817694
[TBL] [Abstract][Full Text] [Related]
3. Lipid-based amphotericin B gel treatment eradicates vulvovaginal candidiasis in patients who failed to azole therapy.
Sheikh S; Ahmad A; Ali SM; Paithankar M; Patel R; Chuadhari S; Dave PM; Bhomia MV; Desai JY; Munshi A; Shah MN; Desai KR; Dongre SA; Walvekar SA; Ahmad I
Arch Dermatol Res; 2023 Sep; 315(7):1939-1944. PubMed ID: 36856855
[TBL] [Abstract][Full Text] [Related]
4. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of oral cochleate-amphotericin B in a mouse model of systemic candidiasis.
Santangelo R; Paderu P; Delmas G; Chen ZW; Mannino R; Zarif L; Perlin DS
Antimicrob Agents Chemother; 2000 Sep; 44(9):2356-60. PubMed ID: 10952579
[TBL] [Abstract][Full Text] [Related]
6. Oral Administration of Human Polyvalent IgG by Mouthwash as an Adjunctive Treatment of Chronic Oral Candidiasis.
Pedraza-Sánchez S; Méndez-León JI; Gonzalez Y; Ventura-Ayala ML; Herrera MT; Lezana-Fernández JL; Bellanti JA; Torres M
Front Immunol; 2018; 9():2956. PubMed ID: 30627128
[No Abstract] [Full Text] [Related]
7. Antifungal efficacy of atorvastatin-containing emulgel in the treatment of oral and vulvovaginal candidiasis.
de Oliveira Neto AS; Souza ILA; Amorim MES; de Freitas Souza T; Rocha VN; do Couto RO; Fabri RL; de Freitas Araújo MG
Med Mycol; 2021 May; 59(5):476-485. PubMed ID: 32823281
[TBL] [Abstract][Full Text] [Related]
8. Artemisinin elevates ergosterol levels of Candida albicans to synergise with amphotericin B against oral candidiasis.
Zhu C; Liao B; Ye X; Zhou Y; Chen X; Liao M; Cheng L; Zhou X; Ren B
Int J Antimicrob Agents; 2021 Sep; 58(3):106394. PubMed ID: 34197906
[TBL] [Abstract][Full Text] [Related]
9. Low intensity ultrasound-mediated drug-loaded nanoparticles intravaginal drug delivery: an effective synergistic therapy scheme for treatment of vulvovaginal candidiasis.
Yang M; Cao Y; Zhang Z; Guo J; Hu C; Wang Z; Du Y
J Nanobiotechnology; 2023 Feb; 21(1):53. PubMed ID: 36782198
[TBL] [Abstract][Full Text] [Related]
10. Phase I EnACT Trial of the Safety and Tolerability of a Novel Oral Formulation of Amphotericin B.
Skipper CP; Atukunda M; Stadelman A; Engen NW; Bangdiwala AS; Hullsiek KH; Abassi M; Rhein J; Nicol MR; Laker E; Williams DA; Mannino R; Matkovits T; Meya DB; Boulware DR
Antimicrob Agents Chemother; 2020 Sep; 64(10):. PubMed ID: 32747357
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and toxicity evaluation of new amphotericin B micelle systems for brain fungal infections.
Moreno-Rodríguez AC; Torrado-Durán S; Molero G; García-Rodríguez JJ; Torrado-Santiago S
Int J Pharm; 2015 Oct; 494(1):17-22. PubMed ID: 26256151
[TBL] [Abstract][Full Text] [Related]
12. A phase 2, open-label study of the safety and efficacy of intravenous anidulafungin as a treatment for azole-refractory mucosal candidiasis.
Vazquez JA; Schranz JA; Clark K; Goldstein BP; Reboli A; Fichtenbaum C
J Acquir Immune Defic Syndr; 2008 Jul; 48(3):304-9. PubMed ID: 18545153
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of caspofungin combined with amphotericin B against azole-resistant Candida albicans.
Hossain MA; Reyes GH; Long LA; Mukherjee PK; Ghannoum MA
J Antimicrob Chemother; 2003 Jun; 51(6):1427-9. PubMed ID: 12716772
[TBL] [Abstract][Full Text] [Related]
14. Treatment of azole-resistant oropharyngeal candidiasis with topical amphotericin B.
Grim SA; Smith KM; Romanelli F; Ofotokun I
Ann Pharmacother; 2002 Sep; 36(9):1383-6. PubMed ID: 12196056
[TBL] [Abstract][Full Text] [Related]
15. Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.
Moen MD; Lyseng-Williamson KA; Scott LJ
Drugs; 2009; 69(3):361-92. PubMed ID: 19275278
[TBL] [Abstract][Full Text] [Related]
16. Novel oral amphotericin B formulation (iCo-010) remains highly effective against murine systemic candidiasis following exposure to tropical temperature.
Wasan KM; Sivak O; Bartlett K; Wasan EK; Gershkovich P
Drug Dev Ind Pharm; 2015; 41(9):1425-30. PubMed ID: 25170660
[TBL] [Abstract][Full Text] [Related]
17. In vivo distribution and therapeutic efficacy of a novel amphotericin B poly-aggregated formulation.
Espada R; Valdespina S; Dea MA; Molero G; Ballesteros MP; Bolás F; Torrado JJ
J Antimicrob Chemother; 2008 May; 61(5):1125-31. PubMed ID: 18285313
[TBL] [Abstract][Full Text] [Related]
18. Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis).
Mendling W; Brasch J; Cornely OA; Effendy I; Friese K; Ginter-Hanselmayer G; Hof H; Mayser P; Mylonas I; Ruhnke M; Schaller M; Weissenbacher ER
Mycoses; 2015 Mar; 58 Suppl 1():1-15. PubMed ID: 25711406
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanism of azoles resistant Candida albicans in a patient with chronic mucocutaneous candidiasis.
Zhang MR; Zhao F; Wang S; Lv S; Mou Y; Yao CL; Zhou Y; Li FQ
BMC Infect Dis; 2020 Feb; 20(1):126. PubMed ID: 32046674
[TBL] [Abstract][Full Text] [Related]
20. VT-1598 inhibits the in vitro growth of mucosal Candida strains and protects against fluconazole-susceptible and -resistant oral candidiasis in IL-17 signalling-deficient mice.
Break TJ; Desai JV; Healey KR; Natarajan M; Ferre EMN; Henderson C; Zelazny A; Siebenlist U; Yates CM; Cohen OJ; Schotzinger RJ; Perlin DS; Garvey EP; Lionakis MS
J Antimicrob Chemother; 2018 Aug; 73(8):2089-2094. PubMed ID: 29788070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
